A detailed history of Capital Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Advisors Inc holds 33,268 shares of ABT stock, worth $3.46 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
33,268
Previous 32,585 2.1%
Holding current value
$3.46 Million
Previous $3.59 Million 5.44%
% of portfolio
0.08%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$109.52 - $120.96 $74,802 - $82,615
683 Added 2.1%
33,268 $3.78 Million
Q4 2023

Jan 29, 2024

SELL
$90.19 - $110.4 $35,264 - $43,166
-391 Reduced 1.19%
32,585 $3.59 Million
Q3 2023

Oct 24, 2023

BUY
$95.53 - $114.62 $5,445 - $6,533
57 Added 0.17%
32,976 $3.19 Million
Q2 2023

Jul 18, 2023

BUY
$100.78 - $112.29 $98,764 - $110,044
980 Added 3.07%
32,919 $3.59 Million
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $49,689 - $58,487
513 Added 1.63%
31,939 $3.23 Million
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $9,125 - $10,705
96 Added 0.31%
31,426 $0
Q3 2022

Oct 17, 2022

SELL
$96.76 - $112.03 $7,257 - $8,402
-75 Reduced 0.24%
31,330 $3.03 Million
Q2 2022

Jul 15, 2022

SELL
$102.07 - $123.37 $31,539 - $38,121
-309 Reduced 0.97%
31,405 $3.41 Million
Q1 2022

May 05, 2022

SELL
$114.02 - $139.04 $30,329 - $36,984
-266 Reduced 0.83%
31,714 $3.75 Million
Q4 2021

Jan 27, 2022

SELL
$115.53 - $141.46 $5,892 - $7,214
-51 Reduced 0.16%
31,980 $4.5 Million
Q3 2021

Oct 25, 2021

SELL
$116.66 - $129.06 $1,166 - $1,290
-10 Reduced 0.03%
32,031 $3.78 Million
Q2 2021

Aug 02, 2021

SELL
$105.79 - $124.53 $20,946 - $24,656
-198 Reduced 0.61%
32,041 $3.72 Million
Q1 2021

May 25, 2021

SELL
$108.84 - $128.23 $36,896 - $43,469
-339 Reduced 1.04%
32,239 $3.86 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $402,885 - $439,029
3,837 Added 13.35%
32,578 $3.57 Million
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $100,345 - $121,862
1,095 Added 3.96%
28,741 $3.13 Million
Q2 2020

Aug 07, 2020

SELL
$76.57 - $98.0 $45,941 - $58,800
-600 Reduced 2.12%
27,646 $2.81 Million
Q1 2020

May 21, 2020

BUY
$62.82 - $91.86 $439 - $643
7 Added 0.02%
28,246 $2.23 Million
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $29,441 - $32,775
375 Added 1.35%
28,239 $2.45 Million
Q2 2019

Aug 07, 2019

BUY
$72.88 - $85.0 $2.03 Million - $2.37 Million
27,864 New
27,864 $0
Q1 2019

May 10, 2019

SELL
$66.22 - $80.06 $2.01 Million - $2.43 Million
-30,413 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $81,950 - $92,837
1,250 Added 4.29%
30,413 $2.2 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $6,506 - $7,849
107 Added 0.37%
29,163 $2.14 Million
Q2 2018

Aug 06, 2018

SELL
$57.57 - $63.54 $10,074 - $11,119
-175 Reduced 0.6%
29,056 $0
Q1 2018

May 04, 2018

BUY
$56.27 - $63.62 $7,033 - $7,952
125 Added 0.43%
29,231 $0
Q4 2017

Jan 29, 2018

BUY
$53.68 - $57.47 $80,788 - $86,492
1,505 Added 5.45%
29,106 $1.66 Million
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $134,808 - $150,460
-2,805 Reduced 9.23%
27,601 $1.47 Million
Q2 2017

Aug 09, 2017

BUY
N/A
30,406
30,406 $1.48 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Advisors Inc Portfolio

Follow Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.